Currently, the sole available treatment for floppy eyelid syndrome is horizontal shortening surgery, which is typically only performed after the patient has suffered from symptoms for some period of time. Crosslinking the upper eyelid tarsus has thus garnered significant interest in the recent literature as it has the potential to become a minimally invasive procedure that could be performed long before the patient progresses to needing surgery.
Although others
3–6 have previously described methodologies for crosslinking tarsus, we are, to the best of our knowledge, the first to use SHG microscopy to study collagen fiber changes after CXL in the tarsus. This also has the advantage of not requiring delicate tissues to be stained or fixed, processes that are known to alter the cellular nanostructure.
10 Using this technique, we found that treating the tarsus with a higher concentration of riboflavin (0.5%) and 365-nm UV-A radiation for 30 minutes (total irradiance 0.45 mW/cm
2) resulted in measurable increased waviness of collagen fibers (
Fig. 9). Correspondingly, histopathology studies showed a distinctly more compact structure. Treatments using lower concentrations of riboflavin with otherwise identical parameters did not result in significant structural changes. This contrasts directly with the studies done by Smith et al
.,
3 who did not find any histopathological changes in crosslinked sheep tarsus despite reporting significant increases in tensile load. It remains to be seen whether histopathological changes are more indicative of long-term, sustainable increases in tissue stiffness.
In lieu of mechanical tensile strength testing, the FRAP technique was chosen in order to allow the study of subtle changes in tissue permeability ex vivo. In agreement with SHG and histopathology, the FRAP assay again showed that only tarsus treated with 0.5% riboflavin showed a significant decrease in permeability. From prior work using the FRAP assay in mouse peripapillary sclera, it can be extrapolated with reasonable certainty that a decrease in permeability corresponds to an increase in tissue stiffness.
11,12
A review of previously published literature on tarsus CXL suggests that the tarsus can indeed be stiffened by irradiation, in agreement with the findings in this study.
6 However, every group differs significantly on the parameters used, particularly the riboflavin concentration, length of irradiation, and total energy of irradiance. For example, Smith et al
.3,4 crosslinked sheep tarsus with 0.1% riboflavin and a 365-nm light source (either mercury bulb or light-emitting diode [LED]) of 45, 50, or 75 mW/cm
2 over 3 minutes (total energy 7.2, 9, or 13.5 J/cm
2, respectively). Ugradar et al
.5 crosslinked thawed cadaveric human eyelids with 1% hypertonic riboflavin solution and a 365-nm LED power source of 6 mW/cm
2 over 18 minutes (total energy, 6.48 J/cm
2). Finally, DeParis et al
.6 crosslinked pig and human tarsus with 0.1% riboflavin and a 370-nm UV-A light (power, 8–9 mW/cm
2) over 60 minutes (total energy, 28.8–32.4 J/cm
2).
Of these methodologies, our study used by far the lowest amount of total energy output (0.81 J/cm
2) to achieve measurable crosslinking. This parameter is critical to consider when attempting to develop any clinical applications, as there are strict regulations in place regarding the exposure of humans to UV-A radiation between 180 and 400 nm.
20 Currently, the Dresden protocol utilizes an irradiance of 5.4 J/cm
2 to the cornea.
21 Our energy output is far below this level in rat tarsus tissue. Human tarsus, which is thicker than rat tarsus, will likely require higher energy levels. Still, it may be beneficial to minimize irradiance in order to prevent collateral damage to surrounding tissue, particularly Meibomian glands. It will be important for clinical models to be able to establish that damage will not occur to adjacent ocular tissues.
Most likely, the lower energy output of this study relates to either the choice of tissue (rat eyelid is thinner than sheep, porcine, or human tarsus) or the concentration of riboflavin used. We found that increasing the concentration of riboflavin (from 0.1% used in the Dresden cornea crosslinking protocol to 0.5%) allowed us to crosslink tissue with low levels of energy. Similarly, Ugradar et al
.5 achieved CXL with the second-lowest energy output (6.48 J/cm
2) and used 1% hypertonic riboflavin. Finally, it may also be true that crosslinking can be achieved with either combination, meaning low energy and high-concentration riboflavin are effective, as well as high energy and lower concentration riboflavin. However, one possible limitation of using a higher concentration of riboflavin is that it may limit the depth of crosslinking. If the riboflavin is highly concentrated at the surface, then this layer will absorb all of the UV-A light. On the other hand, increasing energy output to target deeper tissue could ultimately cause denaturing of surface tissue. Further studies are needed to assess if the scale and durability of crosslinking effects between these two groups are similar and which technique results in the least radiation damage to minimize the clinical side effects with lowest irradiation dose.
This study confirms a methodology by which crosslinking is achieved with low energy output and which has been confirmed with both histological studies and an indirect tissue stiffness assay. However, this study has several limitations. Although the layers of the rat eyelid are histologically similar to the human eyelid, rat tarsus is smaller and thinner than human tarsus. Tarsal tissue from larger animals or human tissue are therefore needed before we can say with certainty that crosslinking at these energy parameters is effective in human tarsus. Additionally, our histopathology studies are mainly qualitative, although they do agree with the more quantitative histology work done by Ugradar et al.
5
Before this model can be successfully translated to an in vivo model, several questions must be answered. Foremost is the question of safety in human tissue. We suggest everting the eyelid and irradiating from the conjunctival side (as was done in this experiment). This should minimize any effects of crosslinking on eyelid tissues overlying the tarsus, as it is known from corneal studies that crosslinking only penetrates to approximately one-third the corneal depth.
22 Furthermore, altering the energy and riboflavin concentration would allow us to control the depth of effect. Ultimately, future experiments in larger species, including a primate model, are needed to determine effects on adjacent tissue and final parameters (riboflavin concentration and radiation energy level and time).
Other considerations include the amount of tarsus that must be treated before a significant effect is seen. We treated the entire length of the tarsus in the upper eyelid; the next step would be to experiment with various treatment sizes and depths in a large animal model. Finally, there may be concern over the longevity of the crosslinking effects. Extrapolating from corneal studies, we expect that tarsus crosslinking will be relatively stable and permanent.
23 We also predict that CXL can be repeated as needed to achieve the desired effect. Future in vivo studies will be necessary to assess the effect of tarsal stiffening and the long-term effects of irradiation on eyelid tissue.